Cancer cells are capable of evading immune recognition and immune-mediated destruction by downregulating the expression of tumor antigens, seizing inhibitory immune checkpoints, and inducing immune exhaustion, which leads to the increased expression of inhibitory receptors on T cells, such as CTLA-4 and PD-1 (16). This evidence concerns the gene CTLA4 and cancer.